MK-677 structure, CAS 159752-10-0

MK-677

CAS Number159752-10-0

SynonymsIbutamoren mesylate (USAN); S1151_Selleck; Ibutamoren; Ibutamoren mesilate; Ibutamoren mesylate; Ibutamoren (Mesylate); MK-0677; MK-0667; MK-677; Crescendo; UNII-R90JB6QJ2B

Molecular FormulaC28H40N4O8S2

Molecular Weight624.769

Purity

Density

Boiling Point868.9ºC at 760 mmHg

Melting Point

Flash Point

Appearancewhite to beige

EINECS

MSDSChineseEnglish

Symboltransportation

Signal WordWarning

Cat. No.: 2A-1169313 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 159752-10-0 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number159752-10-0
Catalog No.2A-1169313
Chinese Name伊布莫仑甲磺酸盐
SynonymsIbutamoren mesylate (USAN); S1151_Selleck; Ibutamoren; Ibutamoren mesilate; Ibutamoren mesylate; Ibutamoren (Mesylate); MK-0677; MK-0667; MK-677; Crescendo; UNII-R90JB6QJ2B
Molecular FormulaC28H40N4O8S2
Molecular Weight624.769
Boiling Point868.9ºC at 760 mmHg
Appearancewhite to beige
Water SolubilityH2O: soluble5mg/mL, clear
Storage Condition2-8°C
ApplicationIbutamoren Mesylate is a potent, non-peptide agonist of the growth hormone secretagogue receptor (GHSR).
PubChem ID11972275
SMILESCC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)CN(c4ccccc34)[S](C)(=O)=O.C[S](O)(=O)=O
InChIInChI=1S/C27H36N4O5S.CH4O3S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27;1-5(2,3)4/h4-12,22H,13-19,28H2,1-3H3,(H,29,33);1H3,(H,2,3,4)/t22-;/m1./s1
InChI KeyInChIKey=DUGMCDWNXXFHDE-VZYDHVRKSA-N
Hazard Symbolstransportation
MSDSmsds/169409_2_159752_10_0.pdf
BioactivityIbutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist. Related Catalog Signaling Pathways >> GPCR/G Protein >> GHSR Research Areas >> Endocrinology In Vivo Ibutamoren mesylate (5 mg/kg/day) results in a statistically significant increases body weight gain and increases serum IGF-1 and GH levels in dogs. Ibutamoren mesylate results in no significant increase in CSF IGF-1 or GH levels on days 7 or 15 of the study[1]. Pretreating mice with GH blocks activation of these neurons by Ibutamoren mesylate (50 μg, i.p.). In the knockout mice, both GH and octreotide fail to inhibit Ibutamoren mesylate activation of arcuate neurons[2]. Chronic oral administration of MK-0677 is associated with significant increases in GH and IGF-I levels that are maintained for the duration of the treatment. The GH profile following MK-0677 administration consists of episodic increases above control[3]. MK-0677 significantly increases peak GH concentrations after oral administration. MK-0677 is a potent GH secretagogue that induces an immediate, large, long lasting increase in GH levels when administered orally or i.v[4]. Animal Admin Compounds used are: Ibutamoren mesylate (50 μg), octreotide (100 μg), and mGH (30 μg). Mice are give an initial ip injection (0.1 mL) of either saline, octreotide or mGH, followed 10 min later by an ip injection (0.1 mL) of either saline or Ibutamoren mesylate. Thus, the first study comprised of the following groups: saline/saline, saline/Ibutamoren mesylate, mGH/saline, mGH/Ibutamoren mesylate saline/saline, saline/Ibutamoren mesylate, mGH/saline, mGH/Ibutamoren mesylate, and the second study of: saline/saline, saline/Ibutamoren mesylate, octreotide/saline, octreotide/Ibutamoren mesylate. Additionally, a number of mice are injected ip with hypertonic saline (0.2 mL, 1.5 M) to serve as positive controls for the immunocytochemistry. Ninety minutes after injection animals are terminally anesthetized with sodium pentobarbitone (60 mg/kg, ip) and perfused transcardially with heparinized saline followed by 4% paraformaldehyde in 0.1mol/Lphosphate buffer (PB, pH 7.4). Brains are then removed and placed in the same solution for 24 h before being stored at− 80°C until processing. Coronal sections of forebrain (40 μM) are cut on a freezing microtome and placed in 0.1mol/LPB containing Triton X-100 (PB-T, pH 7.4). Sections are incubated for 24 h at 4°C in Ab-2 Fos antibody (rabbit polyclonal; 1:1000 in 1% normal sheep serum). The antibody-antigen complex is localized with a 1-h incubation in biotinylated anti-rabbit Ig, followed by a 1-h incubation in avidin, biotinylated horseradish peroxidase. The reaction product is visualized using a glucose oxidase-diaminobenzidine-nickel method, and Fos-like immunoreactivity is visualized as a dense purple-black precipitate restricted to the nucleus. The number of c-fos positive nuclei in the arcuate and periventricular nuclei (six to eight sections per mouse) are counted double-blind and a group mean calculated (mean±sem). Statistical analysis is performed by a two-way ANOVA followed by an all pairwise multiple comparison of data with significance taken as P < 0.05. References [1]. Prahalada S, et al. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration. Horm Metab Res. 1999 Feb-Mar;31(2-3):133-7. [2]. Zheng H, et al. Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol. 1997 Oct;11(11):1709-17. [3]. Hickey GJ, et al. Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. J Endocrinol. 1997 Feb;152(2):183-92. [4]. Jacks T, et al. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles. Endocrinology. 1996 Dec;137(12):5284-9. Chemical & Physical Properties Boiling Point 868.9ºC at 760 mmHg Molecular Formula C28H40N4O8S2 Molecular Weight 624.769 Flash Point 479.3ºC Exact Mass 624.228760 PSA 196.66000 LogP 4.97440 Appearance of Characters white to beige Vapour Pressure 3.05E-32mmHg at 25°C Storage condition 2-8°C Water Solubility H2O: soluble5mg/mL, clear
Use ofIbutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist. Properties Name 2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide,methanesulfonic acid Synonym More Synonyms MK 0677 Biological Activity Description Ibutamoren (Mesylate) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist. Related Catalog Signaling Pathways >> GPCR/G Protein >> GHSR Research Areas >> Endocrinology References [1]. Prahalada S, et al. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration. Horm Metab Res. 1999 Feb-Mar;31(2-3):133-7. [2]. Zheng H, et al. Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol. 1997 Oct;11(11):1709-17. [3]. Hickey GJ, et al. Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. J Endocrinol. 1997 Feb;152(2):183-92. [4]. Jacks T, et al. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles. Endocrinology. 1996 Dec;137(12):5284-9. Chemical & Physical Properties Molecular Formula C28H40N4O8S2 Exact Mass 624.228760 PSA 196.66000 LogP 4.97440 Appearance of Characters white to beige
Transport InfoShipping Name: UN
MSDS Transport InfoModule 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available The above information is believed to be correct, but is not all-inclusive and should be used as a guide only. The information in this document is based on our current knowledge and is Correct safety instructions apply to this product. This information does not represent a warranty as to the properties of this product. See reverse side of invoice or packing slip.
Related Products in Specialty Chemicals
1-Deoxygalactonojirimycin108147-54-22A-1169306
gadoterate meglumine92943-93-62A-1169307
4-Acetoxy-3-acetoxymethylacetophenone24085-06-12A-1169308
PHENYL-2,2,2-TRIFLUOROETHYL-KETONE709-21-72A-1169308
4-NITROSTYRENE100-13-02A-1169309
Indium(III) Acetate251114-58-32A-1169315
Indium(III) Bromide13456-09-32A-1169316
Indium(III) Sulfide12030-04-92A-1169317
ETC-1002738606-46-72A-1169257
4-Methoxyamphetamine 64-13-12A-1169318
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA